REQUEST A DEMO
Total
USD $0.00
Search more companies

Medimat Inko, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Medimat Inko, S.R.O. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Medimat Inko, S.R.O. is based in Czech Republic. The head office is in Hury. It operates in the Pharmacies and Drug Stores sector. The company was established on March 08, 1999. The total number of employees is currently 50 - 99 (2024). The company’s latest financial report indicates a net sales revenue increase of 17.36% in 2022. During that time, Medimat Inko, S.R.O.’s total assets grew by 17.87%. In 2022, Medimat Inko, S.R.O.’s net profit margin decreased by 0.39%.

Headquarters
Prumyslova 276
Hury; Jihocesky; Postal Code: 37371

Contact Details: Purchase the Medimat Inko, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Medimat Inko, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Medimat Inko, S.R.O. report to view the information.
Registered Capital:
Purchase the Medimat Inko, S.R.O. report to view the information.
Incorporation Date:
March 08, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Medimat S.R.O.
100%
Company Performance
Financial values in the chart are available after Medimat Inko, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
17.36%
Total operating revenue
17.37%
Operating profit (EBIT)
13.52%
EBITDA
13.32%
Net Profit (Loss) for the Period
8.02%
Total assets
17.87%
Total equity
25.78%
Operating Profit Margin (ROS)
-0.21%
Net Profit Margin
-0.39%
Return on Equity (ROE)
-4.2%
Debt to Equity Ratio
-8.94%
Quick Ratio
0.14%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?